Efficacy of monthly sodium risedronate for the treatment of corticosteroid induced osteoporosis in patients with rheumatoid arthritis (multicenter, double-blind, randomized, placebo-controlled, parallel-group study )
Phase 4
- Conditions
- osteoporosis, rheumatoid arthritis
- Registration Number
- JPRN-UMIN000015794
- Lead Sponsor
- Division of rheumatology, endcrinology and nephrology, Hokkaido University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who received drugs for osteoporosis within 2 months at inclusion of the study except alphacalcidol and calcitriol Patients who had received bisphosphonates Patients who had undergone the operation of lumbar spine Patients who have a severe decayed tooth to be treated Patients who are considered to be contraindicated for bisphosphonates Patients who are thought to be inappropriate for this study by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method